ANTIDIABETICS AND NSAIDS - PIOGLITAZONE OR ROSIGLITAZONE
The risk of fluid retention with pioglitazone or rosiglitazone is increased by NSAIDs.
Caution is appropriate, and patients should be monitored for signs of heart failure.
Caution is appropriate, and patients should be monitored for signs of heart failure.